Bright.md announced a merger with Vancouver-based MyCare MedTech this week for an innovative customer deployment, setting foot into the global marketplace.
In the United States alone, there are an estimated 20,000 people living with amyotrophic lateral sclerosis (ALS), also called as Lou Gehrig's disease. The fatal disease destroys the nerve cells which control breathing, walking, and eating. Very few people survive more than three years after being diagnosed.
Johnson & Johnson is moving out from the diabetes business and sold its Calibra product (marketed as OneTouch Via, but never launched) to a 10-year-old company named CeQur, which was already working on a similar insulin-delivery wearable. The terms and conditions of this deal have not yet been yet disclosed, but CeQur has attained an exclusive worldwide license for this technology.
Spero Therapeutics granted $15.7 million for research on SPR994, its oral carbapenem-class candidate, to study the drug’s efficacy against biological threats like anthrax, plague and melioidosis as a part of an interagency collaboration.
If a drop of blood is seen in stool, people tend to panic. The causative factors could include digestive, respiratory, circulatory, hematological or even neuropsychological diseases.
San Francisco based Verge Genomics, the Neuroscience based drug discovery company launched in 2015, has raised $32 million in early venture capital financing to bring its AI-generated compounds against Parkinson’s disease and amyotrophic lateral sclerosis (ALS) to clinics within the next three years.
A digital era in the medical field has arisen where one could find the increased utilization of health apps. But a recent analysis by a research team from the University of Sydney in Australia claims that these apps might lead to insignificant diagnosis and wrong information about the illness.
A systematic review revealed the inadequacy of adverse event data in clinical trials of probiotics and prebiotics, rendering it difficult to draw broad conclusions with regards to the safety of interventions to modify gut micro-organisms. These randomized trials assessed probiotics, prebiotics, or synbiotics, which are products that combine probiotics and probiotics.
The Office of the National Coordinator for Health IT which introduced The Certified Health IT Product List Data Challenge in the last week, has initiated a contest for innovative ideas that highlights how its vast and meticulous specs can enhance service to hospitals and health systems.
The CQC rated the South Doc Services Limited as ‘outstanding’ in a report on 11 July. The service operates virtual primary care services for the MyHealthcare GP federation, functioning at several hubs across Birmingham with more than 47 GP practices under its umbrella catering to around 300,000 registered patients. The report praised how the “service used technology to improve treatment and to support patients’ independence”.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.